R. Keith Leonard - 02 Sep 2021 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role
Director
Signature
/s/ Scott Burrows, as Attorney-in-Fact for Keith R. Leonard
Issuer symbol
ARQT
Transactions as of
02 Sep 2021
Transactions value $
$0
Form type
4
Filing time
07 Sep 2021, 19:53:12 UTC
Previous filing
03 Aug 2021
Next filing
26 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARQT Stock Option (Right to Buy) Award $0 +32.9K $0.00 32.9K 02 Sep 2021 Common Stock 32.9K $22.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/3rd of the total shares on each of September 2, 2022, September 2, 2023 and September 2, 2024, subject to Reporting Person's continuous service to the Issuer on each such vesting date.